BMJ Clinical Evidence is one of the world's most authoritative medical resources for informing treatment decisions and improving patient care.
Latest updated reviews
- Atrial fibrillation (acute onset) (updated)
- Atrial fibrillation (chronic) (updated)
- Autism (updated)
- Vitiligo (updated)
- Recurrent miscarriage (updated)
- Congenital toxoplasmosis (updated)
- Hyperthyroidism (updated)
- Pressure ulcers (updated)
- Basal cell carcinoma (new)
- Summary of all updates
Editorial
How much can blood pressure tell us about a treatment for stroke? Or bone mineral density about fracture-prevention strategies? Using surrogate outcomes as a substitute for clinical events may not always give us the complete picture of treatment effectiveness. In our Editorial, Samantha Barton discusses how their use can raise more questions than answers, and contemplates what makes an ideal surrogate outcome.
Drug safety alerts
- FDA issues drug safety alert on neuropsychiatric events (delirium and abnormal behaviour leading to injury) associated with oseltamivir.
(4 March 2008) - MHRA issues drug safety alert on progressive multifocal leukoencephalopathy (PML) associated with mycophenolate mofetil. (18 February 2008)
- MHRA issues drug safety alert on serious hepatic and bullous skin reactions associated with moxifloxacin. (11 February 2008)
Our methods
The systematic reviews in BMJ Clinical Evidence result from a rigorous process aimed at ensuring that they are both reliable and relevant to clinical practice.
Learn about our methods.
Consultancy reviews
Smoking cessation
We present a new review on an evidence-based approach to Smoking cessation.
Managing HIV infection
View our systematic reviews on the challenges of managing HIV/AIDS in resource-poor settings.
May 11, 2008
News Feeds & Email Alerts
Activate your subscription
Handbook & Online subscribers:
Activate your online account
Articles and Research section
Access the latest independent research on BMJ Clinical Evidence









